HUP9902513A2 - Method of producing active immunity with vaccine conjugate - Google Patents
Method of producing active immunity with vaccine conjugateInfo
- Publication number
- HUP9902513A2 HUP9902513A2 HU9902513A HUP9902513A HUP9902513A2 HU P9902513 A2 HUP9902513 A2 HU P9902513A2 HU 9902513 A HU9902513 A HU 9902513A HU P9902513 A HUP9902513 A HU P9902513A HU P9902513 A2 HUP9902513 A2 HU P9902513A2
- Authority
- HU
- Hungary
- Prior art keywords
- active immunity
- vaccine conjugate
- producing active
- vaccine
- conjugate
- Prior art date
Links
- 230000036039 immunity Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000204031 Mycoplasma Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Active immunity against bacterial, protozoal or Mycoplasma disease is produced by administering a vaccine conjugate (I) comprising a live pathogen (A) and neutralising factor (II) bound to (A). (II) is an antibody, or fragment, that can neutralise (A).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902513A HUP9902513A3 (en) | 1997-09-26 | 1997-09-26 | Method of producing active immunity with vaccine conjugate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902513A HUP9902513A3 (en) | 1997-09-26 | 1997-09-26 | Method of producing active immunity with vaccine conjugate |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9902513A2 true HUP9902513A2 (en) | 1999-12-28 |
HUP9902513A3 HUP9902513A3 (en) | 2000-10-30 |
Family
ID=89998851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902513A HUP9902513A3 (en) | 1997-09-26 | 1997-09-26 | Method of producing active immunity with vaccine conjugate |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP9902513A3 (en) |
-
1997
- 1997-09-26 HU HU9902513A patent/HUP9902513A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9902513A3 (en) | 2000-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199900342A1 (en) | METHOD OF CREATING AN ACTIVE IMMUNITY BY VACCINE CONJUGATE | |
NZ529881A (en) | Capsular polysaccharide solubilisation and combination vaccines | |
MY125202A (en) | Vaccine | |
DK0466037T3 (en) | Process for producing a yeast glucan | |
DE69627149D1 (en) | ANTIGENT POLYSACCHARIDE FRAGMENTS WITH A TERMINAL OF 2,5-ANHYDRO-D-MANNOSE GROUP FROM GROUP B-STREPTOCOCCUS, TYPE II AND TYPE III, AND CONJUGATE VACCINE PRODUCED THEREOF | |
NO932102L (en) | Oligosaccharide derived from antigenic polysaccharide obtained from a pathogen | |
IL95867A0 (en) | ||
NZ331299A (en) | Antibody variants with reduced affinity for a cell-surface antigen | |
CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
HUP9902513A2 (en) | Method of producing active immunity with vaccine conjugate | |
MY138203A (en) | Novel bacterial poultry disease | |
PT603386E (en) | PARENTERIC IMMUNIZATION AGAINST ROTAVIRUS | |
MD1855F1 (en) | Method of poultry immunization against viral infections (variants) | |
HUP0002033A2 (en) | Vaccine against diseases caused by chicken parvovirus | |
LV12736A (en) | Method for producing concentrated antigen composition against swine erysipelas disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |